Current status of biosimilars in the treatment of inflammatory bowel diseases
about
Is there a reason for concern or is it just hype? - A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars.Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence.Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model.Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis.
P2860
Current status of biosimilars in the treatment of inflammatory bowel diseases
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Current status of biosimilars in the treatment of inflammatory bowel diseases
@ast
Current status of biosimilars in the treatment of inflammatory bowel diseases
@en
Current status of biosimilars in the treatment of inflammatory bowel diseases
@nl
type
label
Current status of biosimilars in the treatment of inflammatory bowel diseases
@ast
Current status of biosimilars in the treatment of inflammatory bowel diseases
@en
Current status of biosimilars in the treatment of inflammatory bowel diseases
@nl
prefLabel
Current status of biosimilars in the treatment of inflammatory bowel diseases
@ast
Current status of biosimilars in the treatment of inflammatory bowel diseases
@en
Current status of biosimilars in the treatment of inflammatory bowel diseases
@nl
P2860
P356
P1433
P1476
Current status of biosimilars in the treatment of inflammatory bowel diseases
@en
P2093
Dong Il Park
P2860
P356
10.5217/IR.2016.14.1.15
P407
P577
2016-01-01T00:00:00Z